|
Volume 272, Number 36,
Issue of September 5, 1997
pp. 22648-22653
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
The X-ray Structure of the PurR-Guanine-purF Operator
Complex Reveals the Contributions of Complementary Electrostatic
Surfaces and a Water-mediated Hydrogen Bond to Corepressor Specificity
and Binding Affinity*
(Received for publication, June 20, 1997)
Maria A.
Schumacher
,
Arthur
Glasfeld
§,
Howard
Zalkin
¶ and
Richard G.
Brennan

From the Department of Biochemistry and Molecular
Biology, Oregon Health Sciences University, Portland, Oregon
97201-3098, the § Department of Chemistry, Reed College,
Portland, Oregon 97202-8199, and the ¶ Department of
Biochemistry, Purdue University, West Lafayette, Indiana 47907
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
The purine repressor, PurR, is the master
regulatory protein of de novo purine nucleotide
biosynthesis in Escherichia coli. This dimeric
transcription factor is activated to bind to cognate DNA operator sites
by initially binding either of its physiologically relevant, high
affinity corepressors, hypoxanthine (Kd = 9.3 µM) or guanine (Kd = 1.5 µM). Here, we report the 2.5-Å crystal structure of the
PurR-guanine-purF operator ternary complex and complete the
atomic description of 6-oxopurine-induced repression by PurR. As
anticipated, the structure of the PurR-guanine-purF operator complex is isomorphous to the
PurR-hypoxanthine-purF operator complex, and their
protein-DNA and protein-corepressor interactions are nearly identical.
The former finding confirms the use of an identical allosteric
DNA-binding mechanism whereby corepressor binding 40 Å from the
DNA-binding domain juxtaposes the hinge regions of each monomer, thus
favoring the formation and insertion of the critical minor
groove-binding hinge helices. Strikingly, the higher binding affinity
of guanine for PurR and the ability of PurR to discriminate against
2-oxopurines do not result from direct protein-ligand interactions, but
rather from a water-mediated contact with the exocyclic N-2 of guanine,
which dictates the presence of a donor group on the corepressor, and the better electrostatic complementarity of the guanine base and the
corepressor-binding pocket.
INTRODUCTION
The purine repressor, PurR, is a 341-amino acid residue, dimeric
DNA-binding protein from Escherichia coli. In E. coli, PurR functions as the master regulatory protein for de
novo purine nucleotide biosynthesis and, to a lesser extent,
de novo pyrimidine nucleotide biosynthesis and salvage, by
repressing transcription of over 18 genes (1). In addition, PurR
regulates the transcription of several genes encoding proteins
necessary for polyamine and nucleotide biosynthesis (2, 3). Finally,
PurR is autoregulated (4, 5).
PurR belongs to the highly homologous lactose repressor (LacI) family
of transcription regulators (6, 7). Nearly all LacI members function by
binding to similar pseudo-palindromic operator sites typically 16-18
base pairs long. Structurally, LacI members can be divided into two
functional domains: an N-terminal DNA-binding domain (~60 residues)
and a C-terminal oligomerization effector-binding domain (>250
residues). Effector binding serves as a signal of the metabolic state
of the cell, and whereas most LacI proteins bind with high affinity to
their operator sites only in the absence of effector binding, the
specific interaction of PurR with its DNA operator sites is dependent
on corepressor binding. PurR is unique in having two physiologically
relevant corepressors, hypoxanthine, to which it binds with a
Kd of 9.3 µM, and guanine, to which it
binds with higher affinity (Kd = 1.5 µM) (8).
To describe the interactions between PurR and its corepressors
and operator sites, we determined the structure of a
PurR-hypoxanthine-purF operator complex (9). The structure
revealed that PurR has a bipartite structure: a C-terminal
corepressor-binding domain (CBD),1 which spans residues
61-341 and is responsible for dimerization and corepressor binding and
specificity, and an N-terminal DNA-binding domain, which spans residues
1-60. The latter domain is composed of a classical helix-turn-helix
motif that is closed off by a loop and another helix. By engaging in a
series of direct and water-mediated contacts, this three-helix bundle
provides the major groove binding specificity of PurR. It is followed
by another loop and a fourth helix, the hinge helix. The hinge helix,
with a 2-fold related mate, inserts into the DNA minor groove and makes additional specific contacts. Furthermore, hinge helix insertion kinks
the purF operator by permitting the interdigitation of the side chains of Leu54 (and its 2-fold mate,
Leu54 ) between the central CpG base pair step of the
operator (9).
The CBD is oblate in shape and consists of two topologically similar
/ -subdomains (the N- and C-terminal subdomains) that are
connected by three crossover connections. The CBD is structurally similar to the bacterial periplasmic binding proteins (10-12). As
observed in the periplasmic binding proteins, PurR binds hypoxanthine in the cleft between the CBD subdomains through a series of polar, nonpolar, and aromatic interactions (9). Direct and water-mediated contacts are provided by the side chains of Tyr73,
Phe74, Arg190, Thr192,
Phe221, and Asp275. The ability of PurR to
utilize hypoxanthine or guanine, but not adenine and xanthine,
indicates the critical importance of the chemical nature of the
exocyclic 2- and 6-groups in binding specificity. The key PurR residue
that specifies an oxygen at the purine exocyclic 6-position is
Arg190. The guanidinium group of Arg190 donates
two hydrogen bonds to the O-6 acceptor of hypoxanthine (9). Thus, the
side chain donors of Arg190 dictate the requirement for
hydrogen bond acceptors at this purine position. However, the mechanism
of discrimination at the exocyclic 2-group was unclear, as was the
stereochemical basis by which PurR binds guanine more tightly than
hypoxanthine (8).
To begin the structural elucidation of the allosteric mechanism of
PurR, which transduces the signal of corepressor binding by the CBD to
effect DNA binding by the distal DNA-binding domain, the structure of
the corepressor-free CBD was determined (13). From this and the
hypoxanthine-bound PurR structure, the role of that purine corepressor
binding was discerned. Upon binding hypoxanthine, there is a dramatic
rearrangement in the tertiary and quaternary structures of the CBD
N-terminal subdomain that results in the juxtaposition of the two hinge
regions of PurR, which are over 40 Å away (13). Corepressor binding is
essential for this juxtaposition as it shifts the equilibrium from the
open form of PurR, in which the N- and C-terminal subdomains of the CBD
are rotated far apart, to the closed conformation. Although likely, it
was not known if guanine binding causes the identical structural
changes that result in this allosteric shift.
To address the issues of the corepressor specificity and the higher
affinity of PurR for guanine and its possible consequences on the
intramolecular signaling pathway and allostery of this protein, we have
determined the structure of a PurR-guanine-purF operator
complex at 2.5-Å resolution. As expected, the PurR-purF operator contacts and DNA bending are nearly identical to those seen in
the PurR-hypoxanthine-purF operator complex (9). Strikingly, the structure reveals that the higher affinity of guanine for PurR
(over hypoxanthine) and the discrimination against xanthine as a
corepressor arise from 1) a corepressor-water-protein hydrogen bonding network, which involves the exocyclic N-2 hydrogen bond donor
of guanine and the hydrogen bond acceptors, O- of Glu222
and the backbone carbonyl oxygen of Phe221, and 2) the
intrinsic negative electrostatic environment of the corepressor-binding
pocket, which favors the more positive guanine as the corepressor.
EXPERIMENTAL PROCEDURES
Crystallization and Data Collection
PurR was overexpressed
in E. coli and purified by DE53 cellulose and
heparin-agarose chromatography as described (14). Crystals of the
PurR-guanine-purF operator complex were grown by the
hanging-drop vapor diffusion method, which was used previously to
crystallize the PurR-hypoxanthine-purF operator complex (15). Briefly,
protein at a concentration of 0.25-0.50 mM was saturated
with guanine and mixed 1:1 (v/v) with a 0.50 mM solution of
the 16-base pair purF operator, which has an additional
5 -nucleoside overhang on both strands, the identity of which is
irrelevant to crystallization. The protein/corepressor/DNA solution was
mixed 1:1 with the reservoir solution, which was 25% polyethylene
glycol 4000, 0.40 M ammonium sulfate, 25 mM
hexamminecobalt chloride, and 0.10 M ammonium phosphate, pH
7.5. Crystals initially grow as thin two-dimensional plates and, within
a period of 2 weeks to several months, melt and are replaced by large
rhombohedral crystals (typically 0.6 × 0.2 × 0.3 mm). The
PurR-guanine-purF operator crystals are isomorphous to the
PurR-hypoxanthine-purF operator crystals and take the space group C2221, with unit cell dimensions of a = 176.0, b = 95.08, and c = 81.51 Å.
There is one PurR monomer, one guanine molecule, and a purF
operator half-site in the asymmetric unit.
X-ray intensity data were collected at room temperature with an Area
Detector Systems Corp. multiwire area detector (16) and a Rigaku
RU200-H rotating anode operating at 40 kV and 150 mA. The data from two
crystals were processed and merged with the software provided by Area
Detector Systems Corp. The Rmerge of the data to
2.5 Å is 6.29%, and the data are 87% complete from 10.0 to 2.5 Å and 78% from 2.7 to 2.5 Å. The redundancy of the data is 3-fold. The
I/ (I) is 7.4 for the entire data set and 1.4 for the data in the resolution shell between 2.7 and 2.5 Å.
Refinement
The previously determined structure of the
PurR-hypoxanthine-purF operator complex minus the
hypoxanthine and solvent molecules was used as the starting model for
refinement (9). Rigid body refinement was carried out on the model
followed by XYZ and B factor refinement as
implemented in TNT (17). The current model, refined from 10.0 to 2.5 Å, has an R factor of 18.0% and displays excellent
stereochemistry with only two residues, Ser124 and
Asp275 in the unfavorable region of the Ramachandran plot
(18). As observed previously, the unfavorable / angles of
Asp275 are necessary for its interaction with the N-9 atom
of the corepressor (9). Although not directly in contact with the
corepressor, Ser124 is located directly above the
corepressor-binding pocket and takes this conformation to avoid steric
clash with the side chain of
Arg190.2 The root
mean square deviations of bond lengths and bond angles are 0.02 Å and
2.23°, respectively. An Fo Fc omit map, in which the guanine base, residues
221-222, and Wat1 were omitted from the model and followed
by 20 cycles of positional and thermal parameter refinement, is shown
in Fig. 1 (17).
Fig. 1.
Omit map (Fo Fc) of guanine, Wat1,
Phe221, and Glu222. The map was calculated
using structure factors from a structure in which guanine,
Wat1, Phe221, and Glu222 were
removed, and an additional 20 cycles of refinement were carried using
TNT (17). The contour level of the map is 3.5 . The hydrogen bonds
formed between the water molecule (Wat1) and the carbonyl
oxygen of Phe221 and the carboxyl side chain oxygen of
Glu222 are shown. Such a donor-acceptor arrangement leaves
only hydrogen bond acceptors and results in a water-specific
interaction with the exocyclic N-2 of guanine and discrimination
against O-2 of xanthine.
[View Larger Version of this Image (44K GIF file)]
RESULTS AND DISCUSSION
The current model of the PurR-guanine-purF operator
complex includes residues 3-340 of the PurR monomer, one guanine
molecule, a purF operator half-site, and 20 solvent
molecules (Fig. 2). The atomic structures
of PurR and the purF operator are essentially identical to
those seen in the PurR-hypoxanthine-purF operator complex
and display a root mean square deviation of 0.25 Å for all atoms
except solvent (9). Therefore, guanine and hypoxanthine induce the same
DNA binding conformation of PurR. The N-terminal DNA-binding domain
(residues 3-60) consists of a helix-turn-helix-loop-helix motif, which
is responsible for DNA major groove binding specificity, and a hinge
helix, which binds, with its 2-fold related mate, in the minor groove
of the DNA. The insertion of two -helices into the narrow minor
groove is made possible by the partial interdigitation of the hinge
helix residue Leu54 (and Leu54 ) within the
central CpG base pair step. DNA bending, which was calculated with
CURVES (19) and was exclusive of the first and last base pairs of the
16-base pair operator because of their poor electron density, revealed
a 55° kink in the PurR-guanine-purF operator complex
resulting from this side chain partial insertion. This bend is
essentially identical to the 54° bend observed in the structure of
the PurR-hypoxanthine-purF operator complex (9, 20).
Moreover, no significant changes in any base pair or base pair step
parameter were observed.
Fig. 2.
Structure of the PurR-guanine-purF
operator complex. Labeled are the
helix-turn-helix-loop-helix (HTHLH) domain, which is
responsible for major groove specificity (colored red); the hinge helix motif, which mediates minor groove specificity (colored blue); the N-terminal subdomain of the corepressor-binding
domain, residues 61-159 and 294-310 (colored yellow),
which is critical in intramolecular signaling; and the C-terminal
subdomain of the corepressor-binding domain (colored green),
residues 160-298 and 311-341, which imparts dimer stability. The
guanine corepressor is shown as balls and sticks.
The figure was generated with MOLSCRIPT (39).
[View Larger Version of this Image (63K GIF file)]
The CBD consists of two subdomains: the CBD N-terminal subdomain, which
consists of a core of six -strands ( A- E and J) surrounded
by four -helices (I-III and IX), and the CBD C-terminal subdomain,
which consists of a core of five -strands ( F- I and K)
surrounded by five -helices (IV-VIII) (9). Three crossover peptides
connect the two subdomains and serve as a floor to the corepressor,
which is bound in the cleft between the two CBD subdomains. As seen in
the periplasmic binding proteins, these peptidic linkages act as a
hinge to allow movements of subdomains upon ligand association and
dissociation (9-12).
All contacts observed between PurR and the corepressor hypoxanthine in
the PurR-hypoxanthine-purF operator complex are also present
in the PurR-guanine-purF operator complex. Stacking
interactions occur between guanine and the side chains of
Tyr73 and Phe221, which sandwich the
corepressor, and Phe74. Hydrogen bonds are provided by
Thr192, Asp275, and Arg190. O-
of Thr192 hydrogen bonds with N-7 of the guanine ring (2.73 Å, O- -N-7) and also makes van der Waals contact with the
corepressor C-8 via its side chain methyl group. Asp275
makes a hydrogen bond with N-9 of the purine (2.92 Å, O- 2-N-9). The importance of Arg190 in corepressor binding specificity
at the exocyclic 6-position was revealed in the
PurR-hypoxanthine-purF operator complex (9). In the
PurR-guanine-purF operator complex, Arg190 also
specifies an oxygen at the exocyclic 6-position by providing two
hydrogen bonds to this exocyclic amine from its side chain N- and
NH-1 atoms (3.03 Å, N- -O-6; and 2.72 Å, NH-1-O-6).
Arg190 contributes further to corepressor binding affinity
by hydrogen bonding to a water molecule that is simultaneously
hydrogen-bonded to N-1 of the guanine ring (3.15 Å,
H2O-N-1; and 2.72 Å, H2O-NH2). The essentially identical binding observed between PurR and
hypoxanthine and guanine in the PurR-hypoxanthine-purF
operator and PurR-guanine-purF operator complexes and the
identical corepressor-mediated conformations of both complexes reveal
how PurR utilizes two related molecules as corepressors. However, these
interactions do not explain the nearly 7-fold higher affinity of
guanine for PurR or the mechanism by which PurR discriminates at the
purine exocyclic 2-position, i.e. against xanthine.
On the basis of the location of the side chain of Glu222 in
the PurR-hypoxanthine-purF operator complex (9), we
anticipated that upon guanine binding by PurR, this side chain would
swing into the corepressor-binding pocket, eject a tightly bound water molecule (Wat-1), and make a direct hydrogen bond with the exocyclic N-2 atom. However, in the PurR-guanine-purF operator
complex, the position of the side chain of Glu222 has
changed little, and the water molecule is still present, although
slightly shifted in position (Fig. 1). Rather, now the water molecule
is positioned perfectly to hydrogen bond to the exocyclic N-2 of the
guanine ring (2.91 Å, H2O-N-2). This interaction is
specific and discriminatory as both hydrogen bond donors of the water
molecule are taken: one by the carbonyl oxygen atom of
Phe221 (3.10 Å, H2O-O) and the other by
O- 1 of Glu222 (3.06 Å, H2O-O- 1) (Fig.
1). This leaves only the two acceptor lone pairs of this water
molecule, one of which interacts with the guanine N-2 atom and
presumably the other with a hydrogen bond donor from the bulk solvent.
Such a hydrogen bonding network would disfavor the binding of xanthine,
which has an exocyclic acceptor atom (O-2) at this position. Consistent
with this hypothesis is the in vitro binding of xanthine to
PurR, which is ~200-fold weaker than guanine binding (data not
shown). Remarkably, this water molecule is found not only in the
PurR-guanine-purF operator and the
PurR-hypoxanthine-purF operator complexes, but also in the
corepressor-free form of PurR, where the identical water-protein hydrogen bonds are made (13). This demonstrates that this tightly bound
water molecule acts as an extension of the protein.
The importance of water-mediated contacts in ligand binding specificity
is now well documented. Notable examples include members of the
periplasmic binding protein family such as the arabinose-binding protein (21, 22), lysine/arginine/ornithine-binding protein (23), and
oligopeptide-binding protein (OppA) (24); enzymes, e.g.
-chymotrypsin (25); and DNA-binding proteins as exemplified in the
TrpR-tryptophan-trp operator complex (26, 27). In the arabinose-binding protein, two hydrogen-bonded water molecules, located
in the binding pocket, aid in L-arabinose binding while creating an unfavorable interaction with the C-5 methyl group of
D-fucose, thus explaining the low affinity of the latter.
The near equal affinity of the arabinose-binding protein for
D-galactose is explained by the replacement of one of these
water molecules with the D-galactose -CH2OH
group (21, 22). A similar situation is observed in the
lysine/arginine/ornithine-binding protein, where water molecules assist
in the binding of lysine, ornithine, and arginine. However, one of the
water molecules must be displaced to permit binding of the larger
arginine ligand (23). In contrast, OppA provides an example of the use
of solvent in decreasing ligand binding specificity through the
accommodation of multiple substrates with different peptide side chains
in voluminous hydrated cavities from which water molecules are readily
gained or lost (24). In the structure of -chymotrypsin complexed
with a turkey ovomucoid inhibitor, it was demonstrated that a water
molecule, also present in the apo structure, mediated an ionic
interaction that was critical for inhibitor binding specificity (25).
Thus, as in the case of PurR, this water molecule can be considered as
a constitutive element of the protein. Finally, the TrpR-tryptophan
trp operator complex reveals quite dramatically the use of
water molecules to nearly completely specify protein-DNA binding
specificity (26, 27). Thus, through its small molecular size, which
allows it to pack around ligands of different size and shape, and its
ability to provide hydrogen bond donors as well as acceptors, water
provides a key element in the formation of a wide variety of
protein-ligand complexes.
In addition to the direct water-mediated discrimination against
xanthine, an examination of the electrostatic potential of the PurR
corepressor-binding pocket and its proximity reveals a second possible
source of unfavorable xanthine binding as well as the chemical basis of
the more favorable binding of guanine over hypoxanthine. PurR displays
a negative electrostatic potential surface near the exocyclic
2-position of the guanine ring (Fig. 3).
Glu220, Glu222, and Glu70 and
Glu70 from the other subunit contribute to the negative
potential of the binding pocket of PurR. This surface is complemented
by N-2 of guanine, which imparts a significant positive potential to this base. Hypoxanthine, which lacks any exocyclic group at the ring
2-position, is nearly neutral, but is still weakly positive. In
contrast to the physiological corepressors, xanthine possesses a
negative electrostatic potential at its exocyclic O-2 position, which
likely contributes further to its very low affinity (Fig. 4). A similar electrostatic
complementarity is observed between the exocyclic N-2 atom of the
guanine base of GDP and ARF-1 (28), where the N-2 atom is enclosed in a
positive pocket in the protein. This suggests that such electrostatic
complementarity may play a significant role in purine-protein binding
and recognition. In addition to the patch of negative electrostatic
potential near the exocyclic 2-atom of guanine, there is another locus
of negative potential within the corepressor-binding pocket, which is
contributed by Glu248 and Asp275 and
complements the positive potential of the N-9 atom of the purine rings
of guanine and hypoxanthine (Fig. 4). Beyond its contribution to
binding, the charged environment of PurR could serve to steer its
guanine and hypoxanthine corepressors into their bound positions within
the binding pocket. Indeed, electrostatic focusing by narrow clefts
appears to be a general phenomenon, having been perhaps best documented
for copper,zinc-superoxide dismutase (29) and trypsin (30). Thus, a
tight water-mediated hydrogen bond and the negative electrostatic
potential of the corepressor-binding pocket, which complements guanine
better than hypoxanthine, provide a thermodynamic rationale for the
increased affinity of PurR for guanine over hypoxanthine while allowing PurR to maintain the same activated conformation for both corepressors. Combined, these interactions are consistent with the small favorable free energy change ( G 1 kcal/mol, as
calculated by the relationship  G = RT
ln(KdGua/KdHyp) observed
for PurR-guanine binding over PurR-hypoxanthine binding.
Fig. 3.
Complementary electrostatic interactions
between guanine and the corepressor-binding pocket. Shown is a
cut-away surface representation revealing the electronegative potential
of the PurR corepressor-binding pocket, which encompasses the
electropositive exocyclic N-2 of the guanine. This figure was generated
with GRASP (40).
[View Larger Version of this Image (97K GIF file)]
Fig. 4.
Electrostatic potentials of guanine,
hypoxanthine, and xanthine. The atomic charges and electrostatic
potentials are mapped on the van der Waals surfaces of guanine
(A), hypoxanthine (B), and xanthine
(C) and were calculated with a 3-21G* basis set using
Spartan software (Wavefunction Inc., Irvine, CA).
[View Larger Version of this Image (36K GIF file)]
PurR is unique in being the only repressor with two physiologically
relevant corepressors to have had their three-dimensional structures as
well as its corepressor-free form determined at atomic resolution (9,
13). Structures are known for the corepressor-free and -bound forms of
only two other repressors: the tryptophan repressor (TrpR) (27, 31-33)
and the methionine repressor (MetJ) (34-36). The TrpR and MetJ
repressors are similar in that they both bind their corepressors within
their DNA-binding domains. In the case of TrpR, the
L-tryptophan corepressor reorients the flexible DNA-binding
helix-turn-helix reading heads to allow them to fit into successive
major grooves. Moreover, the L-tryptophan makes direct
contacts with the DNA phosphate backbone. For MetJ, the binding of its
corepressor, S-adenosylmethionine, which is located ~12 Å from the DNA backbone, does not appear to result in any conformational
change or structural rearrangement of the MetJ protein (34, 35).
Rather, the electrostatic potential of MetJ becomes decidedly more
positive and might effect, albeit indirectly, the high affinity DNA
binding (36). Clearly, PurR is different and binds its corepressors
within a corepressor-binding pocket, which is at least 40 Å from the
DNA-binding domain. Corepressor binding activates DNA binding
allosterically by repositioning the hinge regions of each PurR monomer
such that they may interact, undergo a coil-to-helix transition (37,
38), and bind the DNA minor groove.
In summary, the structure of the PurR-guanine-purF operator
complex has established that binding of either hypoxanthine or guanine
induces the same activated conformation of PurR, which can then bind
the pur regulon operators with high affinity. The structure
also reveals the likely basis for the higher affinity of PurR for its
guanine corepressor versus hypoxanthine and the stereochemical mechanism of xanthine discrimination: 1) water-mediated readout of the exocyclic 2-position of the purine and 2) better protein-corepressor electrostatic complementarity, notably about the
exocyclic 2-position of the purine ring.
FOOTNOTES
*
This work was supported by United States Public Health
Service Grants GM49244 (to R. G. B.) and GM24658 (to H. Z.) and a
National Defense Science and Engineering Graduate Fellowship in
Biosciences (to M. A. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and structure factors (code 1WET) have
been deposited in the Protein Data Bank, Brookhaven National Laboratory, Upton, NY.
To whom correspondence should be addressed. Tel.:
503-494-4427; Fax: 503-494-8393; E-mail: brennanr{at}ohsu.edu.
1
The abbreviations used are: CBD,
corepressor-binding domain; Wat, water.
2
M. A. Schumacher and R. G. Brennan,
unpublished data.
REFERENCES
-
Zalkin, H., and Dixon, J. E.
(1992)
Prog. Nucleic Acid Res. Mol. Biol.
42,
259-286
[Medline]
[Order article via Infotrieve]
-
Steiert, J. G., Rolfes, R., Zalkin, H., and Stauffer, G. V.
(1990)
J. Bacteriol.
172,
3799-3803
[Abstract/Free Full Text]
-
He, B., Choi, K. Y., and Zalkin, H.
(1993)
J. Bacteriol.
175,
3598-3606
[Abstract/Free Full Text]
-
Rolfes, R. J., and Zalkin, H.
(1990)
J. Bacteriol.
172,
5758-5766
[Abstract/Free Full Text]
-
Meng, L., Kilstrup, M., and Nygaard, P.
(1990)
Eur. J. Biochem.
187,
373-379
[Medline]
[Order article via Infotrieve]
-
Weickert, M. J., and Adhya, S.
(1992)
J. Biol. Chem.
267,
15869-15874
[Abstract/Free Full Text]
-
Ngyuen, C. C., and Saier, M. H., Jr.
(1995)
FEBS Lett.
377,
98-102
[CrossRef][Medline]
[Order article via Infotrieve]
-
Choi, K. Y., and Zalkin, H.
(1992)
J. Bacteriol.
174,
6207-6214
[Abstract/Free Full Text]
-
Schumacher, M. A., Choi, K. Y., Zalkin, H., and Brennan, R. G.
(1994)
Science
266,
763-770
[Abstract/Free Full Text]
-
Müller-Hill, B.
(1983)
Nature
302,
163-164
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bowie, J. V., Lüthy, R., and Eisenberg, D.
(1991)
Science
253,
164-170
[Abstract/Free Full Text]
-
Quiocho, F. A.
(1991)
Curr. Opin. Struct. Biol.
1,
922-933
[CrossRef]
-
Schumacher, M. A., Choi, K. Y., Zalkin, H., and Brennan, R. G.
(1995)
Cell
83,
147-155
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rolfes, R., and Zalkin, H.
(1990)
J. Bacteriol.
172,
5637-5642
[Abstract/Free Full Text]
-
Schumacher, M. A., Choi, K. Y., Zalkin, H., and Brennan, R. G.
(1994)
J. Mol. Biol.
242,
302-305
[CrossRef][Medline]
[Order article via Infotrieve]
-
Xuong, N., Nielsen, C., Hamlin, R., and Andersen, D.
(1985)
J. Appl. Crystallogr.
18,
342-350
[CrossRef]
-
Tronrud, D. E., TenEyck, L. J., and Matthews, B. W.
(1987)
Acta Crystallogr. Sect. A
43,
498-501
-
Laskowski, R. A., MacArthur, M. W., and Thornton, J. M.
(1993)
J. Appl. Crystallogr.
26,
283-291
[CrossRef]
-
Lavory, R., and Sklenar, H.
(1990)
J. Biomol. Struct. & Dyn.
6,
215-235
-
Glasfeld, A., Schumacher, M. A., Choi, K. Y., Zalkin, H., and Brennan, R. G.
(1996)
J. Am. Chem. Soc.
118,
13073-13074
[CrossRef]
-
Quiocho, F. A., Wilson, D. A., and Vyas, N. K.
(1989)
Nature
340,
404-407
[CrossRef][Medline]
[Order article via Infotrieve]
-
Vyas, N. K., Vyas, M. N., and Quiocho, F. A.
(1991)
J. Biol. Chem.
266,
5226-5237
[Abstract/Free Full Text]
-
Yao, N., Trakhanov, S., and Quiocho, F. A.
(1994)
Biochemistry
33,
4769-4779
[CrossRef][Medline]
[Order article via Infotrieve]
-
Tame, J. R. H., Sleigh, S. H., Wilkinson, A. J., and Ladbury, J. E.
(1996)
Nat. Struct. Biol.
3,
998-1001
[CrossRef][Medline]
[Order article via Infotrieve]
-
Fujinaga, M., Sielecki, A. P., Read, R. J., Ardelt, W., Laskowski, M., and James, M. N. G.
(1987)
J. Mol. Biol.
195,
397-418
[CrossRef][Medline]
[Order article via Infotrieve]
-
Otwinowski, Z., Schevitz, R. W., Zhang, R.-G., Lawson, C. L., Joachimiak, A., Marmorstein, R. Q., Luisi, B. F., and Sigler, P. B.
(1988)
Nature
334,
321-329
-
Joachimiak, A., Haran, T. E., and Sigler, P. B.
(1994)
EMBO J.
13,
367-372
[Medline]
[Order article via Infotrieve]
-
Greasley, S. E., Jhoti, H., Teahan, C., Solari, R., Fensome, A., Thomas, G. M. H., Cockcroft, S., and Bax, B.
(1995)
Nat. Struct. Biol.
2,
797-806
[CrossRef][Medline]
[Order article via Infotrieve]
-
Getzoff, E. D., Tainer, J. A., Weiner, P. K., Kollman, P. A., Richardson, J. S., and Richardson, D. C.
(1983)
Nature
306,
287-290
[CrossRef][Medline]
[Order article via Infotrieve]
-
Klapper, I., Hagstrom, R., Fine, R., Sharp, K., and Honig, B.
(1986)
Proteins Struct. Funct. Genet.
1,
47-59
[CrossRef][Medline]
[Order article via Infotrieve]
-
Schevitz, R. W., Otwinowski, Z., Joachimiak, A., Lawson, C. L., and Sigler, P. B.
(1985)
Nature
317,
782-786
[CrossRef][Medline]
[Order article via Infotrieve]
-
Zhang, R.-G., Joachimiak, A., Lawson, C. L., Schevitz, R. W., Otwinowski, Z. O., and Sigler, P. B.
(1987)
Nature
327,
591-597
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lawson, C. L., and Carey, J.
(1993)
Nature
366,
178-182
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rafferty, J. B., Somers, W. S., Saint-Girons, I., and Phillips, S. E. V.
(1989)
Nature
341,
705-710
[CrossRef][Medline]
[Order article via Infotrieve]
-
Somers, W. S., and Phillips, S. E. V.
(1992)
Nature
359,
387-393
[CrossRef][Medline]
[Order article via Infotrieve]
-
Phillips, K., and Phillips, S. E. V.
(1994)
Structure
2,
309-316
[Medline]
[Order article via Infotrieve]
-
Spolar, R. S., and Record, M. T.
(1994)
Science
263,
777-784
[Abstract/Free Full Text]
-
Nagadoi, A., Morikawa, S., Nakamura, H., Enari, M., Kobagashi, K., Yamamoto, H., Sampei, G., Mizobuchi, K., Schumacher, M. A., Brennan, R. G., and Nishimura, Y.
(1995)
Structure
3,
1217-1224
[Medline]
[Order article via Infotrieve]
-
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950
[CrossRef]
-
Honig, B., and Nicholls, A.
(1995)
Science
268,
1144-1149
[Abstract/Free Full Text]
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Ye, G. Vriend, and A. P. IJzerman
Tracing evolutionary pressure
Bioinformatics,
April 1, 2008;
24(7):
908 - 915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Perez-Rueda and J. Collado-Vides
The repertoire of DNA-binding transcriptional regulators in Escherichia coli K-12
Nucleic Acids Res.,
April 15, 2000;
28(8):
1838 - 1847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Johnson and G. M. Church
Predicting ligand-binding function in families of bacterial receptors
PNAS,
April 11, 2000;
97(8):
3965 - 3970.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|